Boehringer Ingelheim has revealed sales of its bovine viral diarrhoea (BVD) vaccine in the UK have passed the 500,000 mark.

Image: © Fotolia/Robbinsbox.
Since its UK launch, Bovela has been used to protect more than half a million cattle. Image: © Fotolia/Robbinsbox.

In the 18 months since it was launched on the UK market, Bovela has been used to protect more than half a million cattle.

With BVD back on the agenda following the launch of England’s voluntary BVD eradication scheme, Wales soon to launch its own scheme and the Scottish scheme making progress, the company expects high uptake of the vaccine to continue.

Firm favourite

Boehringer business manager Robert Bakewell said: “There is no doubt the vaccine has found itself as a firm favourite with farmers and vets in a relatively short space of time.

“As a single-shot vaccine that can be used in cattle from three months old onwards, Bovela is unique in the market. Other vaccines require a two-dose primary course with annual boosters or, in some cases, six-monthly boosters.

“These factors, and the fact Bovela brings innovation and a new level of immunity in the form of a live double-deleted vaccine, make Bovela a dramatically different product to other vaccines on the market.”

Double protection

In other European countries, while BVD eradication schemes have reduced the prevalence of the disease, eliminating the tail of residual infection is said to be key to a country successfully becoming free of the disease.

Mr Bakewell added: “Bovela can be used alongside these schemes to ensure once a herd is free of BVD, it keeps infection out.

“Additionally, while BVD type one is the most commonly found strain of the virus, BVD type two has caused issues in some countries with and without eradication schemes, such as the Netherlands, Belgium, Germany and Spain, with the added issue that the old vaccines only provide fetal protection against type one.”

BVD type two can be a more aggressive strain of the virus, causing high numbers of deaths in herds where it is diagnosed. Bovela is the only UK licensed vaccine to provide proven protection against both BVD type one and type two.

For more information, visit Boehringer Ingelheim’s website.

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz

related content

Ceva Santé Animale has gained a diversified portfolio of products from Boehringer Ingelheim following its acquisition of Merial Animal Health.

Highly pathogenic avian influenza H5N8 is spreading across the UK and mainland Europe, and is expected to remain an issue “for a considerable time”, Defra has warned.

12 mins

Boehringer Ingelheim Animal Health is celebrating after selling four billion doses of vaccines against Mycoplasma hyopneumoniae, porcine circovirus disease and porcine reproductive and respiratory syndrome.

3 mins

Defra has confirmed an outbreak of avian influenza in a flock of about 6,000 birds at a second Lincolnshire turkey farm.

2 mins

A leading authority on Schmallenberg virus is warning farm vets to be prepared for the possibility of a springtime spike in cases of abnormal births and deformities in sheep and cattle.

4 mins

Scientists believe they may have identified the mystery cause of “shaking piglets” – cases of which have been reported in Europe and abroad since the 1920s.

3 mins